We are a part of creating the future

Research and development at Vita 34

Vita 34 has its own innovation division for research and development, which contributes essentially to innovations being lived and realized in the company. Innovation processes at Vita 34 are characterized by particularly target-oriented and detailed development. In the course of researching and establishing new therapies in the field of regenerative medicine, stem cells are gaining more and more importance.

Vita 34 was the first private stem cell bank in Europe to open up the way to individual precaution to the public by means of the possibility of storing stem cells. The constant enhancement of the range of products and services has maintained its importance to Vita 34.

Constant enhancement of the product range

I like dealing with that subject so much, because innovations in all Vita 34 divisions are indispensable for further growth from the strategic point of view.”

Dr. André Gerth (CEO)

As a stem cell bank we are proud to say, that in the course of 2018 we will launch the option for parents to combine private precautions and public donation.

Cord blood is way to important to go to waste! In countries with public stem cell banks, the parents are given the choice to store stem cells privately or donate publicly. In the course of 2018 Vita 34 will be able to offer a combination of both to our customers. We call it Vita Mine&Yours.

 

Process innovations and process optimization

Process innovations are indispensable and of utmost importance for the company. The materials used for collection, preparation, and storage are being constantly improved (e.g. proprietary development of collection kit and cryo-bag), production steps are optimized and entirely new production methods developed.

Vita 34 is THE pioneer on the market of stem cell banks and has been advancing innovations for many years. To keep it this way in the future, we are determined to bring a new service, a new product or a new production method onto the market every year. Vita 34 thereby ensures to meet the demands and needs of the market in the future – and to further increase customer satisfaction. The purpose of all our efforts is to provide all people with access to new products and therapies on the basis of stem cells.

 

  • The Association for the Promotion of Science and Humanities in Germany, a joint economic initiative, awarded Vita 34 a seal for commitment in research. The association stands up for the long-term improvement of the German educational and research environment.

  • Vita 34 is GMP-certified. All preparations are produced in line with good manufacturing practice and are of a certified quality. This is how we create the basis for the safe application of umbilical cord blood.

  • TOP 100 awards the most innovative German small and medium-sized business. This year Vita 34 was awarded as TOP innovator for its intensive research and development activities.

Safety kit for collection and transport

Our innovative collection kit is a storage box and a temperature monitored transport package in one. Apart from the sterile collection utensils, the kit also contains an electronic measuring chip that monitors temperature thus providing for optimal and safe transport of both cord blood and cord tissue.

Innovative blood bag

Tear-resistant, break-proof and cold resistant: Stems cells practically do not age any more at minus 180 degrees Celsius. Normal plastics, however, become brittle and can break at this temperature. For this reason we developed a freezing bag, after many years of research, in which the umbilical cord blood can really be stored reliably.

Hotline manned 24/7 by midwives

Our midwives are specially trained in the collection of your child's stem cells from the umbilical cord. We have a midwife ready at our Hotline any time of the day and night. You can always get in touch with us! By calling our Hotline you can arrange the details regarding collection at the birth. This means that the entire process of collection, packing and transport is handled very safely and by causing as little disturbance to you as possible.

Special courier

Fast. Reliable. 365 Days a Year. We work with a special courier so that the umbilical cord blood and tissue arrives at our stem cell laboratory quickly and reliably. This courier both knows and observes the special transport conditions in detail.

Personal counseling

If a treating physician has decided that your child's stem cells may be used for treatment, you will have all the practical help and support that you need from our stem cell experts. They will also assist in establishing contact to specialists.

Mobile stem cell team

If the stem cells are needed in case of a severe disease, Vita 34 specialists bring the umbilical cord blood to the hospital. Prior to handing it over to the physician, we test the quality of the umbilical cord blood again and, if he/she so requests, prepare it for the transplantation on-site.

Official permits

Complicated permit procedures, strict safety measures and active research ensure that your child’s umbilical cord blood can be used in new therapies in the future. The Paul-Ehrlich Institute, an entity of the German Federal Ministry of Health has granted us the necessary permits for this. In the Nordic countries we obtain the necessary permits from the respective authorities. In Denmark Styrelsen for Patientsikkerhed, in Norway Helsedirektoratet and in Sweden IVO.

Insolvency insurance

To date, the parents of almost 145,000 children have stored umbilical cord blood and tissue with Vita 34. As a reliable partner, we have also taken provisions against financial risks for you. No one knows what the future will bring. One thing however, is sure: The proper ongoing storage of your child’s stem cell deposit is ensured in any case for 50 years. Even if unforeseen circumstances should arise. HDI-Global SE guarantees the proper ongoing storage of the stem cell deposits for 50 years from the start of storage in the case of insolvency. If Vita 34 in the Nordic region ceases the activity all samples and associated data are taken over by the company in Germany